This statistic depicts the pharmaceutical market size in selected countries in Latin America in 2017. That year, Brazil sold almost ************ pharmaceutical units, followed by Mexico with *** million units sold.

The Biopharmaceutical Industry Market report segments the industry into By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, and more), By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, and more), and Geography.

Biopharmaceuticals Market was valued at USD 154 Billion in 2017 and anticipated to grow at 13.3% CAGR during the forecast period.

The Russian pharmaceutical market reached approximately *** trillion Russian rubles in 2024, marking a **-percent increase from the previous year. The value of pharmaceutical sales was forecast to increase to nearly *** trillion Russian rubles in 2025.

Biologics Market - Global industry segment analysis, regional outlook, share, trends, growth; biologics market forecast 2017 to 2025 by BIS Research

Commercial sales occupied the largest share of the pharmaceutical market in Russia, forecast to exceed *** trillion Russian rubles in 2025. The value of pharmaceuticals acquired via public procurement increased over the period under consideration, measuring at**** billion Russian rubles in 2024.

• The global industry was valued at US$ 515.6 Bn in 2022
• It is projected to grow at a CAGR of 6.9% from 2023 to 2031 and reach more than US$ 855.8 Bn by 2031

Market Introduction

Attribute	Detail
Driver	Strong Pipeline with Accelerated Approval

Regional Outlook of Global Biologics Industry

Attribute	Detail
Leading Region	North America

Global Biologics Market Snapshot

Attribute	Detail
Market Value in 2022	US$ 515.6 Bn
Market Forecast Value in 2031	More than US$ 855.8 Bn
Growth Rate (CAGR)	6.9%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.
Competition Landscape	Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Product Monoclonal Antibodies Recombinant Proteins Vaccines Cell & Gene Therapy Others Application Oncology Autoimmune & Immunological Disorders Hematological Disorders Infectious Diseases Others (Cardiovascular Disorders, etc.) Manufacturing Outsourced In-house
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain China Japan India Australia & New Zealand Brazil Mexico GCC Countries South Africa
Companies Profiled	AbbVie Amgen AstraZeneca Bristol-Myers Squibb Company Eli Lilly Gilead Sciences, Inc. GlaxoSmithKline Johnson & Johnson Services Inc. Merck & Co., Inc. Novartis AG Pfizer Inc. F. Hoffmann-La Roche AG and Others Other Players
Customization Scope	Available upon request
Pricing	Available upon request

• The industry was valued at US$ 23.4 Bn in 2022
• It is estimated to grow at a CAGR of 9.5% from 2023 to 2031 and reach US$ 52.6 Bn by the end of 2031

Market Introduction

Attribute	Detail
Drivers	Surge in Demand for Biopharmaceuticals Rise in Adoption of Personalized Medicines

Biopharmaceutical Fermentation Systems Market Regional Insights

Attribute	Detail
Leading Region	North America

Biopharmaceutical Fermentation Systems Market Snapshot

Attribute	Detail
Market Value in 2022 (Base Year)	US$ 23.4 Bn
Market Forecast Value in 2031	US$ 52.6 Bn
Growth Rate (CAGR)	9.5%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Units	US$ Bn for Value
Market Analysis	Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape	Prominent Players – Competition Dashboard and Revenue Share Analysis, 2022 Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format	Electronic (PDF) + Excel
Market Segmentation	Product Upstream Products Fermenters Bioprocess Analyzers Process Monitoring Devices Culture & Media Preparation Culture Media and Buffers & Inducers Other Upstream Products Downstream Products Filtration & Separation Systems Chromatography Consumables & Accessories Other Downstream Products Application Recombinant Proteins Monoclonal Antibodies Antibiotics Probiotics Others (Amino Acids, Enzymes, Polysaccharides, etc.) End-user Biopharmaceutical Companies Contract Manufacturing Organizations Contract Research Organizations Academic Research Institutes Food Industry Others
Regions Covered	North America Latin America Asia Pacific Europe Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain Russia & CIS China India Japan ASEAN Brazil Mexico South Africa
Companies Profiled	GE Healthcare Thermo Fisher Scientific Inc. Danaher Corporation Sartorius Stedim Biotech Merck KGaA Eppendorf AG F. Hoffmann-La Roche Ltd. Nova Biomedical Lonza Group AG BD
Customization Scope	Available upon Request
Pricing	Available upon Request

In 2021, the market size of small-molecule targeted cancer drugs in China exceeded ************* U.S. dollars, representing a *** percent increase from 2017. The market is expected to expand further to almost ** billion U.S. dollars in 2026. Small-molecule drugs are drugs that can enter cells easily thanks to their low molecular weight. They can affect other molecules, such as proteins, inside the cells, and may cause cancer cells to die.

The global biologic excipient market is projected to be appraised at US$ 2,241.8 million by 2034, up from US$ 1500 million in 2024, advancing at a CAGR of 4.10% from 2024 to 2034.

Attributes	Key Insights
Market Size in 2024	US$ 1,500 million
Market Value in 2034	US$ 2,241.8 million
Value-based CAGR from 2024 to 2034	4.10%

Mapping the Growth Trail of the Biologic Excipient Market from 2019 to 2023 and the Path to the Future from 2024 to 2034

Historical CAGR from 2019 to 2023	3.90%
Forecast CAGR from 2024 to 2034	4.10%

Country-wise Analysis

Countries	Forecast CAGRs from 2024 to 2034
The United States	3.70%
Germany	4.50%
The United Kingdom	4.0%
China	3.40%
India	3.90%

Category-wise Insights

Category	Market Share
Polymers	30.10%
Biopharmaceutical Manufacturers	65.70%

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 1,500 million
Projected Market Valuation in 2034	US$ 2,241.8 million
Value-based CAGR 2024 to 2034	4.10%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Excipients Type End Users Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	FMC Corporation Wacker Chemie AG Evonik Industries AG Ashland Global Holdings Inc. Archer-Daniels-Midland Co. Roquette Freres S.A. The Dow Chemical Company Colorcon Inc. Signet Chemical Co. Pvt. Ltd. Sun Pharmaceutical Industries Ltd

• The industry was valued at US$ 177.9 Mn in 2022
• It is estimated to advance at a CAGR of 10.3% from 2023 to 2031 and reach US$ 426.8 Mn by the end of 2031

Pharmaceutical Robots Market Snapshot

Attribute	Detail
Market Size in 2022	US$ 177.9 Mn
Market Forecast (Value) in 2031	US$ 426.8 Mn
Growth Rate (CAGR)	10.3%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Tons	US$ Mn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2022) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Type Traditional Robots Articulated Robots SCARA (Selective Compliance Articulated Robot Arm) Robots Delta/Parallel Robots Cartesian Robots Other Robots (Spherical and dual-arm robots) Collaborative Robots Application Picking and Packaging Pharmaceutical Drugs Inspection Laboratory Applications End-user Pharmaceutical Companies Research Laboratories
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Spain Italy Japan China India Australia & New Zealand Brazil Mexico South Africa GCC countries
Companies Profiled	Kawasaki Heavy Industries, Ltd. FANUC Corporation KUKA AG ABB Yaskawa Electric Corporation Mitsubishi Electric Corporation Denso Corporation Universal Robots A/S Shibuya Corporation Seiko Epson Corporation
Customization Scope	Available upon request
Pricing	Available upon request

The biologics drug development market was estimated at $2.79 billion in 2017 and is expected to grow over $8.46 billion by 2027. Global biologics drug development industry report: Focus on market research report, industry analysis, share, size, share, growth, trends and forecast.

In 2022, empty pharmaceutical capsules in Japan had a market share of about **** percent in the Asia Pacific region. The market share showed a gradual increase since 2017 and was forecast to reach nearly **** percent by 2028.

The BCMA targeted therapies market is likely to grow from USD 9.2 Bn in 2024 to USD 11.8 Bn in 2025 and USD 85.9 Bn by 2035, representing a CAGR of 21.9%

According to Cognitive Market Research, the global Pharmaceutical Testing Analytical Services Market size will be USD 9582.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 9.50% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 3545.64 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2033.
Europe accounted for a market share of over 29% of the global revenue with a market size of USD 2779.01 million.
APAC held a market share of around 24% of the global revenue with a market size of USD 2299.87 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2033.
South America has a market share of more than 3.8% of the global revenue with a market size of USD 364.15 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2033.
Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 383.31 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2033.
Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 210.82 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2033.
Medical device companies are the fastest-growing segment of the pharmaceutical testing analytical services market

Market Dynamics of Pharmaceutical Testing Analytical Services Market

Key Drivers for Pharmaceutical Testing Analytical Services Market

Surge In Clinical Trials Drives Pharmaceutical Analytical Testing Services Market Growth

The growing number of clinical trials is expected to fuel the growth of the pharmaceutical analytical testing services market. Clinical trials are research studies that use human participants to determine the safety and efficacy of medical treatments or interventions. Healthcare analytical testing services are used in clinical trials to evaluate drug safety and efficacy, dosing and formulation, data integrity, and quality assurance. For instance, according to ClinicalTrials.gov, a division of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, the number of registered studies increased from 437,523 in 2022 to 468,457 in all 50 states and 221 countries as of October 2023. Furthermore, it was reported that 143,613 studies (31% of the total) are registered in the United States alone, while 251,159 studies (54% of the total) are registered in non-U.S. locations. As a result, an increasing number of clinical trials are expected to drive the growth of the pharmaceutical analytical testing services market

https://www.bumc.bu.edu/ohra/clinicaltrials-gov/clinicaltrials-gov-what-why-which-studies-when/”/

Rising chronic disease cases drive the pharmaceutical analytical testing services market

The rising prevalence of chronic diseases is expected to drive the Pharmaceutical analytical testing services market in the coming years. Chronic diseases are those that last longer than three months in humans and include arthritis, asthma, cancer, diabetes, and other conditions. Millions of patients suffering from chronic diseases rely on healthcare analytical testing services for early detection and treatment. According to Firstpost, an India-based online news and media website, the number of diabetes cases in India is expected to double to 134 million by 2025. As a result, rising chronic disease rates are propelling the pharmaceutical analytical testing service market forward

https://www.firstpost.com/india/diabetes-is-indias-fastest-growing-disease-72-million-cases-recorded-in-2017-figure-expected-to-nearly-double-by-2025-4435203.html”/

Restraint Factor for the Pharmaceutical Testing Analytical Services Market

High costs of advanced analytical testing Will Limit Market Growth

High analytical testing costs hinder market growth in the pharmaceutical testing and analytical services market. These tests typically require complex devices, skilled workers, and advanced training, resulting in higher operational costs for testing laboratories. As a result, small businesses are unable to afford these services, limiting their competitive and innovative capabilities. Furthermore, high investment costs can discourage investmen...

According to Cognitive Market Research, the global Pharmaceutical Drying Equipment market size will be USD 5628.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 2082.6 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1632.3 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 1350.9 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 213.90 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 225.1 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 123.84 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2033.
Spray category is the fastest growing segment of the Pharmaceutical Drying Equipment industry

Market Dynamics of Pharmaceutical Drying Equipment Market

Key Drivers for Pharmaceutical Drying Equipment Market

Expansion of Pharmaceutical Manufacturing Facilities to Boost Market Growth

The growing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases has significantly increased the global demand for pharmaceutical products. In 2022, North America accounted for 52.3% of global pharmaceutical sales, far surpassing Europe’s 22.4%. According to IQVIA (MIDAS, May 2023), 64.4% of newly launched medicines between 2017 and 2022 were introduced in the U.S. market, compared to just 16.4% in Europe’s top five markets. The global prescription pharmaceutical market was valued at approximately €1,222,921 million (or $1,287,736 million) at ex-factory prices in 2022. North America (comprising the U.S. and Canada) maintained its position as the world’s largest pharmaceutical market, significantly ahead of Europe, China, and Japan. To address this rising demand, pharmaceutical companies are actively expanding their manufacturing capabilities worldwide. For example, Takeda Pharmaceuticals invested around USD 750 million in a new plasma-derived therapy production facility in Japan in 2023, while BeiGene launched a clinical R&D center and biologics manufacturing plant in the U.S. in July 2024. Such developments are driving the need for advanced pharmaceutical drying equipment to ensure the efficient processing of active pharmaceutical ingredients (APIs) and maintain high product quality.

https://www.efpia.eu/media/rm4kzdlx/the-pharmaceutical-industry-in-figures-2023.pdf/.//./

Rising Demand for Biopharmaceuticals and Personalized Medicine to Boost Market Growth

The biopharmaceutical sector is undergoing rapid expansion, largely fueled by the growing emphasis on personalized medicine and the increasing development of biologics. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S.-based biopharmaceutical companies invested approximately $96 billion in research and development (R&D) in 2023, representing over 20% of their total sales. The industry's overall economic footprint in the U.S. is substantial. In 2022 alone, more than $25 billion in biopharmaceutical exports originated from majority foreign-owned companies operating within the country. These firms also invested nearly $26 billion in R&D during the same year. Furthermore, foreign direct investment in the U.S. pharmaceutical and medicine sector reached $503.4 billion in 2023. Biopharmaceutical products—such as vaccines, monoclonal antibodies, and hormones—demand highly specialized drying processes to ensure their stability and effectiveness. Technologies like freeze dryers and vacuum dryers are crucial for handling these sensitive compounds without degrading product quality. As the biopharmaceutical industry continues to expand, it serves as a major growth driver for the pharmaceutical drying equipment ...

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

ATTRIBUTES	DETAILS
STUDY PERIOD	2017-2030
BASE YEAR	2024
FORECAST PERIOD	2025-2030
HISTORICAL PERIOD	2017-2024
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Thermo Fisher, Merck, Corning, Cytiva(Danaher Corporation), Lonza, Fujifilm, Sartorius Stedim Biotech, HiMedia Laboratories, Guangdong Shuanglin Biopharmaceutical, Oaks Biopharmaceuticals, OPM Biosciences, Zencore Biologics, Bio-Engine
SEGMENTS COVERED	By Product Type - With Serum, Serum-free By Application - Pharmaceutical Companies, Laboratory By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa

Biological safety cabinet market size, trends & analysis, by product type (pharmaceutical & biopharmaceutical), by application (labs, pharmacy), by region, forecasts - [2017-2034].

Gene synthesis market size, growth & analysis, by product type (gene library synthesis, custom gene synthesis), by end-use (research organizations, academic & research institutes, biopharmaceutical companies), by region, forecast - [2017-2034].

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

ATTRIBUTES	DETAILS
STUDY PERIOD	2017-2030
BASE YEAR	2024
FORECAST PERIOD	2025-2030
HISTORICAL PERIOD	2017-2024
UNIT	VALUE (USD MILLION)
KEY COMPANIES PROFILED	Roche, GlaxoSmithKline, Bayer, Pfizer, Merck, Zhongsheng Pharmaceutical, Teyi Pharmaceutical, Chengdu Brilliant Pharmaceutical Co. Ltd., Borui Pharmaceutical (Suzhou) Co. Ltd., Jiangsu Nuotai Osano Biopharmaceutical Co. Ltd., Sunflower Pharmaceutical, Yabao Pharmaceutical
SEGMENTS COVERED	By Product Type - Antiviral Drug, Cough and Expectorant, Antipyretic By Application - Hospital, Clinic, Others By Sales Channels - Direct Channel, Distribution Channel By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa